Tag Archives: CPX351

Celator® Pharmaceuticals Announces VYXEOS™ (CPX-351) Selected As Best

Celator® Pharmaceuticals Announces VYXEOS™ (CPX-351) Selected As Best
EWING, N.J., Oct. 27, 2015 /PRNewswire/ — Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that VYXEOS™ (formerly referred to as CPX-351) was recognized with the Nanomedicine Award 2015. This award recognizes projects or products …
Read more on PR Newswire (press release)

Nanopharmaceutical Industry and Market: Companies, Products, R&D and Revenue
Do you want to find sales potentials of nanomedicine? If so, our new analysis gives you revenue forecasts to 2025 at overall world market, application, product and national level. That way you discover financial data, trends, R&D, opportunities and …
Read more on PR Newswire (press release)

Launching the Nanomedicine Academy of Minority Serving Institutions
Nanomedicine uses nanotechnology for the prevention, diagnosis, and treatment of disease. Northeastern boasts several pioneers in the field, including Thomas Webster, the Art Zafiropoulo Chair in Engineering and the chair of Northeastern's chemical …
Read more on Nanowerk